Galenica AG (SWX: GALE)
Switzerland
· Delayed Price · Currency is CHF
75.55
+0.55 (0.73%)
Nov 18, 2024, 1:50 PM CET
Galenica AG Revenue
Galenica AG had revenue of 1.91B CHF in the half year ending June 30, 2024, with 8.20% growth. This brings the company's revenue in the last twelve months to 3.80B, up 2.99% year-over-year. In the year 2023, Galenica AG had annual revenue of 3.76B with 4.47% growth.
Revenue (ttm)
3.80B
Revenue Growth
+2.99%
P/S Ratio
1.00
Revenue / Employee
478.08K
Employees
7,902
Market Cap
3.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.76B | 160.81M | 4.47% |
Dec 31, 2022 | 3.60B | -246.19M | -6.41% |
Dec 31, 2021 | 3.84B | 356.57M | 10.23% |
Dec 31, 2020 | 3.48B | 178.60M | 5.40% |
Dec 31, 2019 | 3.31B | 134.90M | 4.25% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 60.58B |
Roche Holding AG | 60.58B |
Novartis AG | 42.18B |
Lonza Group AG | 6.70B |
Galderma Group AG | 3.88B |
Sonova Holding AG | 3.63B |
Straumann Holding AG | 2.54B |
Ypsomed Holding AG | 617.07M |